Merge Labs — Valuation, Funding & Investors

Merge Labs is a research lab with the long-term mission of bridging biological and artificial intelligence to maximize human ability, agency, and experience. It is developing fundamentally new approaches to brain-computer interfaces that interact with the brain at high bandwidth, integrate with advanced AI, and are ultimately safe and accessible for anyone to use. Merge Labs is structured as a long-term research organization and a Public Benefit Corporation.

Co-founders include Sam Altman, CEO of OpenAI, participating in a personal capacity, Alex Blania, co-founder of World, and Mikhail Shapiro, professor of Chemical and Medical Engineering at Caltech. Merge Labs is a brain-computer interfaces company with 23 job openings, and it is currently valued at $0.9 billion as a private company.

Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Merge Labs.

Often trade at a premium or discount to NAV.

Platforms match existing holders with buyers. Merge Labs availability at any moment is set by the holders.

High minimums, transfer approval, company right-of-first-refusal.

Valuations, rounds and IPO status for every company in the directory — Merge Labs included.

The last valuation is $850M.

Lead investors for each round are in the funding timeline.

The routes section explains what is realistically available for a company at this stage.

No. Merge Labs is a private company; its shares do not trade on a public exchange.